UBS has received its first conditional approval from the Office of the Comptroller of the Currency for a national bank charter in the United States, bringing the Swiss bank a significant step closer to full banking status for its U.S. franchise. The conditional approval follows more than a year of regulatory review and comes with detailed requirements on governance, risk management and capital adequacy. UBS will now work through the prescribed operational milestones, including the implementation of enhanced compliance systems and the appointment of a U.S.-based chief risk officer. Full charter status would allow UBS to benefit from federal deposit insurance and streamlined capital rules, improving funding flexibility for its local wealth management and investment banking units.

In a recent equity research note, UBS analysts lowered their recommendation on GE HealthCare shares to ‘sell’, warning that competition from Chinese rivals and the rapid entrance of generic alternatives could erode market share and margins more quickly than consensus forecasts suggest. The report highlights that GE HealthCare’s international revenue could face a 10–15% shortfall by 2027 if leading Chinese equipment makers capture even 5% of key imaging markets. UBS also models a potential 20% compression in diagnostic service pricing across Europe by 2028, amplifying the risk to the company’s installed base and service contracts. Investors are urged to reassess exposure given these downside scenarios.

UBS forecasts that gold prices will continue to climb, building on a near 65% surge during 2025 and an additional 7% advance so far this year. The bank’s commodities research team points to central bank diversification strategies, persistent real negative yields in developed markets and heightened geopolitical tension in Eastern Europe and the Middle East as primary catalysts. UBS models gold reaching new all-time highs by mid-2026 if real U.S. yields remain below zero and if net central bank purchases exceed 1,000 tonnes annually. The firm also highlights portfolio rebalancing flows, estimating that a mere 0.5% shift of global equity assets into bullion would equate to roughly $100 billion in fresh demand.

In an interview with Swiss newspaper Tages-Anzeiger, UBS Group CEO Sergio Ermotti reiterated his preference for selecting his successor from within the bank’s ranks. Ermotti, who returned to the top job in 2021 and has overseen record net profit margins above 30% in 2025, underscored the depth of talent in UBS’s wealth management, investment banking and asset management divisions. He noted that internal candidates benefit from institutional knowledge of UBS’s risk framework and global culture. The board has commenced preparatory work on a formal succession timetable, with a final appointment expected in late 2026 to ensure a smooth handover and continuity of the bank’s strategic priorities.